Deck Mount Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 7 Months
About Deck Mount Pharmaceuticals
Deck Mount Pharmaceuticals Private Limited (DMPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 June 2021 (Three years and seven months 24 days old ). Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Paramjit Singh and Mankaran Ahluwalia serve as directors at the Company.
Company Details
-
Location
Gurugram, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232HR2021PTC095517
-
Company No.
095517
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Jun 2021
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Deck Mount Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Paramjit Singh
|
Director | 09-Jun-2021 | Current |
|
Mankaran Ahluwalia
|
Director | 09-Jun-2021 | Current |
Financial Performance of Deck Mount Pharmaceuticals.
Enhance accessibility to Deck Mount Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deck Mount Pharmaceuticals?
Unlock access to Deck Mount Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Maktech Auto Private LimitedMankaran Ahluwalia is a mutual person
-
Deck Mount Beverages Private LimitedParamjit Singh and Mankaran Ahluwalia are mutual person
-
Highland Drinks Private Limited
Paramjit Singh is a mutual person
-
United Drinks Private Limited
Paramjit Singh is a mutual person
-
Sugene Beauty Clinic Private Limited
Paramjit Singh is a mutual person
-
Metaocean Ventures Private Limited
Paramjit Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Deck Mount Pharmaceuticals?
Deck Mount Pharmaceuticals has a workforce of 0 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deck Mount Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deck Mount Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.